RizwanDNuraniMD

Radiation Oncology • Apple Valley, CA

Physician

Join to view full profile

Are you Dr. Nurani?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 22 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
18092 Wika Rd
Ste 140
Apple Valley, CA 92307
Phone+1 760-503-5910

Fax+1 760-242-8577

Summary

Dr. Rizwan Nurani, MD is a radiation oncologist in Apple Valley, California. He is currently licensed to practice medicine in California, Hawaii, and Florida. He is affiliated with El Camino Health and El Camino Hospital Los Gatos.

Education & Training

University of WashingtonResidency, Radiation Oncology, 2003 - 2007
Deaconess Medical Center (Spokane)Internship, Transitional Year, 2002 - 2003
University of Washington School of MedicineClass of 2002

Certifications & Licensure

CA State Medical License 2011 - 2025
FL State Medical License 2007 - 2023
HI State Medical License 2012 - 2020
WA State Medical License 2006 - 2020
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Most Compassionate Doctor American Registry

Publications & Presentations

PubMed

27 citations
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial.
Neil F Mariados, Peter F Orio 3rd, Zvi Schiffman, Thanh John Van, Alexander Engelman
JAMA Oncology. 2023-04-01
3 citations
The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure
Nathan Bittner, Kent E. Wallner, Gregory S. Merrick, Peter F. Orio, Rizwan Nurani
American Journal of Clinical Oncology. 2008-06-01
2 citations
Multicenter, dual fractionation scheme, single core lab comparison of rectal volume dose reduction following injection of two biodegradable perirectal spacers.
Michael Kos, Rizwan Nurani, Paulo Costa, Mateuzs Dabkowski, Joana Vale Ferreira da Silva
Journal of Applied Clinical Medical Physics. 2023-10-01

Press Mentions

Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual MeetingMay 1st, 2024
Northern California Prostate Cancer Center Joins the US Oncology Network, Advancing Quality Care and Operational EfficiencyJuly 9th, 2019